[Antibodies to cytomegaloviruses in blood donors].
The use of seronegative blood products is important to prevent transfusion-associated cytomegalovirus infection in immunocompromised patients. We have screened 3,458 normal blood donors for CMV-IgG-antibodies with an ELISA to receive a panel of seronegative donors and to determine the antibody prevalence. 1,948 donors were seropositive. Female donors had higher antibody prevalence than males in each age range tested.
Courault
K
K
Bezirks-Institut für Blutspende und Transfusionswesen Berlin.
Lissé
I
I
Richter
H
H
D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis*; D001604:Berlin; D001782:Blood Donors; D001803:Blood Transfusion; D003430:Cross-Sectional Studies; D003587:Cytomegalovirus / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000635:transmission*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D008297:Male; D008875:Middle Aged; D012307:Risk Factors
D000914:Antibodies, Viral; D007074:Immunoglobulin G
Antikörper gegen Cytomegalievirus bei Blutspendern.